Results 21 to 30 of about 2,083,027 (293)

Patient reported outcome and experience measures of oral disease in oral medicine [PDF]

, 2017
A recent meeting of health ministers from over 40 countries worldwide deemed that time and money should be spent on outcome and experience measures that would allow us to determine whether our health systems deliver outcomes that truly matter to patients.
Ni Riordain, R, Wiriyakijja, P
core   +1 more source

Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature

Biomedicines, 2023
Osteoradionecrosis (ORN) is a serious long-term complication of head and neck radiotherapy (RT), which is often triggered by dental extractions. It results from avascular aseptic necrosis due to irradiated bone damage. ORN is challenging to treat and can
Giulia Corrao, Giovanni Carlo Mazzola, Niccolò Lombardi, Giulia Marvaso, Alberto Pispero, Elisa Baruzzi, Sem Decani, Marco Tarozzi, Luca Bergamaschi, Chiara Lorubbio, Ilaria Repetti, Anna Starzyńska, Daniela Alterio, Mohseen Ansarin, Roberto Orecchia, Fiorella D’Amore, Roberto Franchini, Andrea Nicali, Paolo Castellarin, Andrea Sardella, Giovanni Lodi, Elena Maria Varoni, Barbara Alicja Jereczek-Fossa   +22 more
doaj   +1 more source

Periodontal Inflamed Surface Area Mediates the Link between Homocysteine and Blood Pressure

Biomolecules, 2021
Here, we assess the association between homocysteine (Hcy) serum levels and periodontal status in a large representative sample of the National Health and Nutrition Examination Survey (NHANES).
João Botelho, Vanessa Machado, Yago Leira, Luís Proença, José João Mendes   +4 more
doaj   +1 more source

Persistent oral mucosal lesions preceding diagnosis of Crohn's disease and primary sclerosing cholangitis

Clinical Case Reports, 2023
Oral mucosal lesions may persist years before symptoms or diagnosis of inflammatory bowel disease (IBD) and subsequent primary sclerosing cholangitis (PSC).
Karita Nylund, Jaana Helenius‐Hietala, Fredrik Åberg, Jaana Hagström, Hellevi Ruokonen   +4 more
doaj   +1 more source

Oral medicine case book 74: marijuana-induced Oral Leukoplakia [PDF]

, 2017
A 55-year-old male presented at the Oral Medicine Clinic of the University of the Western Cape, Oral Health Centre, Tygerberg Campus, for the evaluation of a persistent white patch on his right edentulous mandibular ridge.
Afrogheh, Amir, Holmes, Haly, Mulder Van Staden, Sune, Temilola, Dada   +3 more
core   +1 more source

Alveolar bone loss is associated with oral cancer: a case-control study

Frontiers in Oral Health
BackgroundA link between chronic inflammation and malignant transformation is evident in various cancer types. Periodontitis is the most common chronic inflammatory condition in oral medicine with a proven association with systemic diseases like diabetes.
Leah Trumet, Leah Trumet, Roman Fuchs, Roman Fuchs, Joy Backhaus, Bettina Grötsch, Kerstin Galler, Marco Kesting, Marco Kesting, Manuel Weber, Manuel Weber   +10 more
doaj   +1 more source

Mucoceles of the oral cavity : a large case series (1994-2008) and a literature review [PDF]

, 2010
Objectives: Evaluating data of patients affected by oral mucoceles, examined at the Unit of Oral Medicine and Pathology of the University of Milan between January 1994 and December 2008.
Achilli, Antonio, Carrassi, Antonio, Demarosi, Federica, Lodi, Giovanni, Re Cecconi, Dario, Sardella, Andrea, Tarozzi, Marco   +6 more
core   +1 more source

Multiplex immunofluorescence assessment of macrophages and IL-23R in inflammatory and malignant diseases of the oral mucosa: a pilot study

Frontiers in Immunology
BackgroundImmune cells play a major role in the development and progression of inflammatory and malignant diseases of the oral mucosa. There is growing evidence that immune cells contribute to oral cancer progression and metastases.
Leah Trumet, Leah Trumet, Bettina Grötsch, Abbas Agaimy, Kerstin Galler, Carol Geppert, Linus Winter, Linus Winter, Jutta Ries, Jutta Ries, Marco Kesting, Marco Kesting, Manuel Weber, Manuel Weber   +13 more
doaj   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson, Menna Shamma, Upeka Senanayake, Shaimaa Sahmoud, Kathleen Duffin, Victoria Howard, David King, Ayesha Fathani, Blanche Lumb, Andrei Pobischan, Irum Latif Memon, Monzir Ahmed, Rhian Thomas, Gerard Millen, Yasmeen Alomari, Sucheta Vaidya, Lynley V. Marshall, Sally L. George, Ramya Ramanujachar, Juliet Gray, Paola Angelini   +20 more
wiley   +1 more source

Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]

, 2015
Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi, Hacıoğlu, Sibel Kabukçu, Keskin, Ali, Sarı, İsmail   +3 more
core   +2 more sources